Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
Found 14 records
$199,815.00
Mar 1, 2021
Academia
There are many vaccine candidates using other technologies that are currently in development in Canada and overseas such as instance Providence Therapeutics, Medicago, and VBI. This Project proposes a modeling framework that can be applied to test new candidates and compare to those that have been approved/distributed in Canada.
$173,000,000.00
Oct 18, 2020
For-profit organization
The Project is in direct response to the global fight against COVID-19. The Project will be undertaken in two stages to (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale GMP Facility for vaccine and antibody production in Canada.
$200,000,000.00
Oct 18, 2020
For-profit organization
The project is in direct response to the global fight against COVID-19. The project will be undertaken in two stages: (1) develop a plant-derived virus-like particle (VLP) vaccine for the prevention of COVID-19; and (2) establish a large-scale Good Manufacturing Practice (GMP) Facility for vaccine and antibody production in Canada.
$2,515,000.00
Jan 1, 2019
For-profit organization
Development of a plant-derived candidate universal influenza vaccine ready for clinical development
$2,515,000.00
Jan 1, 2019
For-profit organization
Development of a plant-derived candidate universal influenza vaccine ready for clinical development
$64,167.00
Apr 1, 2018
The genetic basis, ecological mediators, and evolutionary consequences of tradeoffs between attracting mutualists and repelling parasites in the legume genus Medicago
$1,313,019.00
Dec 13, 2017
$34,000.00
May 10, 2017
$371,615.00
Apr 25, 2017
$8,000,000.00
May 13, 2015
Monies allocated over more than one fiscal year;Repayable Contribution